Creating sustainability and longevity for biosimilars

Provider Insights

Biosimilars Check Up: Physician Perspectives on Biosimilar Adoption

We asked 100 physicians to share their insights on anticipated utilization and confidence in biosimilars. See what they said.

Download the results

Connect With an Expert

Sean McGowan, Sr. Director, Biosimilars at amerisourcebergen
Contact Sean

Market Insights

Biosimilars: Shaping a Moving Market

What does the biosimilar market look like now, where is it headed, and how can manufacturers ensure their therapies thrive as it becomes increasingly competitive? Get a glimpse at the changing landscape in our animated infographic.

View now

RICK LOZANO, VICE PRESIDENT, BIOSIMILARS, AMERISOURCEBERGEN
"Recent patent litigation decisions signal that supporters of the biosimilar channel need to work even harder to communicate the value and opportunity for these products and create confidence among payers, providers and patients."

We advance access with integrated commercialization services for all biosimilars

"The right conditions exist in the U.S. for biosimilar commercialization success. Competition has proven to bring prices down – look at the generics market over the last 30 years – but now we need to create a supportive system."

STEVE COLLIS, CHAIRMAN, PRESIDENT AND CEO, AMERISOURCEBERGEN 

Read more

AmerisourceBergen has access to 100% of launched biosimilars in the U.S.

biosimilars currently available through AmerisourceBergen 

For a complete list of approved biosimilars, refer to FDA biosimilar product information. Commercial launches can take 10-12 months from FDA approval.


Our relationships span:
health systems
95%
of u.s. hospitals
oncology
60%
of U.S. community oncology market
nephrology
90%
of U.S. renal market
rheumatology
2,100
provider sites
opthamology
4,200
provider sites

Resources & Education

Read the FDA's guidance on biosimilars and get answers to patients' frequently asked questions.

Connect With an Expert

Find out more about how AmerisourceBergen can support your product or practice as the biosimilars market in the U.S. expands.
Two women speaking in an office


Get in touch

Our integrated portfolio of solutions and decades of industry experience make us the right partner for your product's successful journey to commercialization. Start a conversation with us to see how we can provide the strategies you need for optimal product performance. 
Connect With an Expert